Related Experiment Video
Updated: Oct 26, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.4K
A Comparative Analysis of Machine Learning Algorithms to Predict Alzheimer's Disease
Morshedul Bari Antor1, A H M Shafayet Jamil1, Maliha Mamtaz1
1Electrical and Computer Engineering Department, North South University, Dhaka 1229, Bangladesh.
Journal of Healthcare Engineering
|August 2, 2021
Summary
This study explored machine learning models for detecting Dementia, a key factor in Alzheimer's disease. Support Vector Machine models showed the highest accuracy in identifying Dementia patients.
Area of Science:
- Neuroscience
- Medical Imaging
- Machine Learning
Background:
- Alzheimer's disease is a major global health concern, affecting millions and causing progressive cognitive decline.
- Dementia, a primary symptom of Alzheimer's, significantly impairs thinking and reading abilities.
- Early detection of Dementia is crucial for managing Alzheimer's disease.
Purpose of the Study:
- To develop and evaluate machine learning models for predicting Dementia.
- To compare the performance of various algorithms in identifying Dementia patients.
Main Methods:
- Utilized the Open Access Series of Imaging Studies (OASIS) dataset.
- Applied and compared Support Vector Machine, Logistic Regression, Decision Tree, and Random Forest algorithms.
- Evaluated model performance with and without fine-tuning.
Main Results:
- Support Vector Machine demonstrated the highest accuracy in Dementia detection among the tested models.
- Fine-tuning improved the performance of the machine learning models.
- The developed system offers a simple approach for identifying Dementia.
Conclusions:
- Machine learning, particularly Support Vector Machine, shows significant promise for accurate Dementia detection.
- The findings suggest a potential tool for early identification and management of Alzheimer's disease.
- Further research with larger datasets could enhance the system's generalizability.
Related Concept Videos
Alzheimer's Disease: Overview
879
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
879
Alzheimer's Disease: Treatment
419
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
419

